Golden State Equity Partners’s Sanofi SNY Stock Holding History

Golden State Equity Partners’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$328K	Buy	6,813 +1,126	+20%	+$52.5K	0.02%	556
2025 Q4	$276K	Buy	5,687 +940	+20%	+$46.6K	0.04%	415
2025 Q3	$224K	Sell	4,747 -835	-15%	-$40.3K	0.04%	407
2025 Q2	$270K	Buy	5,582 +1,139	+26%	+$58.2K	0.05%	355
2025 Q1	$246K	Buy	+4,443	New	+$240K	0.05%	371
2024 Q4	–	Sell	-2,316	Closed	-$133K	–	801
2024 Q3	$133K	Buy	+2,316	New	+$125K	0.07%	241
2022 Q1	$442K	Buy	+8,600	New	+$444K	0.22%	114

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Golden State Equity Partners's SNY Position: Q1 2026 in Review

Golden State Equity Partners increased its Sanofi (SNY) stake by 20% in Q1 2026, buying an estimated $52.5K and bringing the position to 6,813 shares worth $328K. The position accounts for 0.02% of the portfolio, ranked #556.

Golden State Equity Partners first reported a position in SNY in Q1 2022 and has held it in 7 quarters since. The position peaked at $442K in Q1 2022. 738 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

Golden State Equity Partners held 6,813 shares of Sanofi worth $328K as of Q1 2026.
Golden State Equity Partners bought 1,126 Sanofi shares in Q1 2026, an estimated $52.5K.
Sanofi made up 0.02% of Golden State Equity Partners's portfolio in Q1 2026, its #556 holding.
Golden State Equity Partners first reported a position in Sanofi in Q1 2022 and has held it in 7 quarters since.
Golden State Equity Partners's Sanofi position peaked at $442K in Q1 2022.
738 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on Golden State Equity Partners's 13F filing for Q1 2026, filed 28 Apr 2026.